TY - JOUR
T1 - The therapeutic effect of hysterosalpingography in couples with unexplained subfertility
T2 - a post-hoc analysis of a prospective multi-centre cohort study
AU - Dreyer, K.
AU - van Eekelen, R.
AU - Tjon-Kon-Fat, R. I.
AU - van der Steeg, J. W.
AU - Steures, P.
AU - Eijkemans, M. J.C.
AU - van der Veen, F.
AU - Hompes, P. G.A.
AU - Mol, B. W.J.
AU - van Geloven, N.
N1 - Funding Information:
Declaration: This study was facilitated by grant 945/12/002 from ZonMW, The Netherlands Organization for Health Research and Development, The Hague, The Netherlands. The funders had no role in study design, collection, analysis and interpretation of the data. BWM is supported by a NHMRC Practitioner Fellowship (GNT1082548). BWM reports consultancy for ObsEva, Merck and Guerbet.
Publisher Copyright:
© 2018 Reproductive Healthcare Ltd.
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Research question: Hysterosalpingography (HSG) with an oil-based contrast has been shown to increase ongoing pregnancy rates compared with HSG with water-based contrast, but it remains unclear if an effect of HSG occurs compared with no HSG. Design: A secondary data-analysis of a prospective cohort study among 4556 couples that presented with unexplained subfertility in 38 clinics in the Netherlands between January 2002 and December 2004. A time-varying Cox regression with inverse probability of treatment weighing was used to analyse ongoing pregnancy rates in women after undergoing the HSG procedure (with the use of either water- or oil-based contrast media) compared with women who did not undergo HSG. Results: The probability of natural conception within 24 months after first presentation at the fertility clinic was increased after HSG, regardless of the type of contrast medium used, compared with no HSG (adjusted hazard ratio 1.48, 95% CI 1.26 to 1.73, corresponding to an absolute increase in 6-month pregnancy rate of +6%). When this analysis was limited to HSGs that were made with water-contrast, the treatment effect remained (adjusted hazard ratio 1.40, 95% CI 1.16 to 1.70). Conclusions: HSG increases the ongoing pregnancy rate of couples with unexplained subfertility compared with no HSG, regardless of the contrast medium used. Results need to be validated in future, preferably randomized, studies.
AB - Research question: Hysterosalpingography (HSG) with an oil-based contrast has been shown to increase ongoing pregnancy rates compared with HSG with water-based contrast, but it remains unclear if an effect of HSG occurs compared with no HSG. Design: A secondary data-analysis of a prospective cohort study among 4556 couples that presented with unexplained subfertility in 38 clinics in the Netherlands between January 2002 and December 2004. A time-varying Cox regression with inverse probability of treatment weighing was used to analyse ongoing pregnancy rates in women after undergoing the HSG procedure (with the use of either water- or oil-based contrast media) compared with women who did not undergo HSG. Results: The probability of natural conception within 24 months after first presentation at the fertility clinic was increased after HSG, regardless of the type of contrast medium used, compared with no HSG (adjusted hazard ratio 1.48, 95% CI 1.26 to 1.73, corresponding to an absolute increase in 6-month pregnancy rate of +6%). When this analysis was limited to HSGs that were made with water-contrast, the treatment effect remained (adjusted hazard ratio 1.40, 95% CI 1.16 to 1.70). Conclusions: HSG increases the ongoing pregnancy rate of couples with unexplained subfertility compared with no HSG, regardless of the contrast medium used. Results need to be validated in future, preferably randomized, studies.
KW - Diagnostic workup
KW - Hysterosalpingography
KW - Natural conception
KW - Tubal patency test
KW - Unexplained subfertility
UR - http://www.scopus.com/inward/record.url?scp=85058637294&partnerID=8YFLogxK
U2 - 10.1016/j.rbmo.2018.11.005
DO - 10.1016/j.rbmo.2018.11.005
M3 - Article
C2 - 30579824
AN - SCOPUS:85058637294
SN - 1472-6483
VL - 38
SP - 233
EP - 239
JO - Reproductive Biomedicine Online
JF - Reproductive Biomedicine Online
IS - 2
ER -